PharVision Advisers’s nLIGHT LASR Stock Holding History

PharVision Advisers’s Portfolio LASR Stock Details LASR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,327	Closed	-$350K	–	396
2025 Q4	$350K	Sell	9,327 -6,781	-42%	-$226K	0.18%	193
2025 Q3	$477K	Buy	+16,108	New	+$399K	0.27%	30

Other funds holding LASR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PharVision Advisers's LASR Position: Q1 2026 in Review

PharVision Advisers sold out of nLIGHT (LASR) in Q1 2026, closing a stake of 9,327 shares — an estimated $350K sold.

PharVision Advisers first reported a position in LASR in Q3 2025 and held it in 2 quarters. The position peaked at $477K in Q3 2025. 330 funds tracked by Wall St. Rank hold LASR as of Q1 2026.

PharVision Advisers reported no remaining nLIGHT position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 9,327 nLIGHT shares in Q1 2026, an estimated $350K.
PharVision Advisers first reported a position in nLIGHT in Q3 2025 and held it in 2 quarters.
PharVision Advisers's nLIGHT position peaked at $477K in Q3 2025.
330 funds tracked by Wall St. Rank held nLIGHT as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.